Optimizing the diagnosis and the treatment of iron overload diseases

被引:37
作者
Brissot, Pierre [1 ]
机构
[1] Univ Hosp Pontchaillou, Hepatol Fac Med, Natl Ctr Reference Rare Iron Overload Dis, Inserm UMR 991, 2 Ave Pr Leon Bernard, F-35043 Rennes, France
关键词
Iron chelation; Ferritin; Ferroportin; Hemojuvelin; Iron overload; Venesection; Transferrin saturation; Hemochromatosis; Non-transferrin bound iron; Hepcidin; LABILE PLASMA IRON; HEREDITARY HEMOCHROMATOSIS; NONINVASIVE ASSESSMENT; MOUSE MODEL; LIVER IRON; THALASSEMIA; HEPCIDIN; GENE; PATHOLOGY; ERYTHROFERRONE;
D O I
10.1586/17474124.2016.1119043
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A number of human disorders are related to chronic iron overload, either of genetic or acquired origin. The multi-organ damage produced by iron excess leads, in adults and in children, to severe clinical consequences, affecting both quality of life and life expectancy. The diagnosis is increasingly based on a non-invasive strategy, resorting to clinical, biological and imaging data. The treatment rests on either venesection or chelation therapy, depending on the etiology. Major advances in the fields of molecular biology, pharmacology, and biotechnology pave the road for key improvements in the diagnostic and therapeutic management of the patients.
引用
收藏
页码:359 / 370
页数:12
相关论文
共 66 条
  • [31] Eighty percent of French sport winners in Olympic, World and Europeans competitions have mutations in the hemochromatosis HFE gene
    Hermine, Olivier
    Dine, Gerard
    Genty, Vincent
    Marquet, Laurie-Anne
    Fumagalli, Gabriela
    Tafflet, Muriel
    Guillem, Flavia
    Van Lierde, Francoise
    Rousseaux-Blanchi, Marie-Philippe
    Palierne, Christian
    Lapostolle, Jean-Claude
    Cervetti, Jean-Pierre
    Frey, Alain
    Jouven, Xavier
    Noirez, Philippe
    Toussaint, Jean-Francois
    [J]. BIOCHIMIE, 2015, 119 : 1 - 5
  • [32] NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY
    HERSHKO, C
    GRAHAM, G
    BATES, GW
    RACHMILEWITZ, EA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) : 255 - 263
  • [33] A new mutation in the hepcidin promoter impairs its bone morphogenetic protein response and contributes to a severe phenotype in HFE related hemochromatosis
    Island, Marie-Laure
    Jouanolle, Anne-Marie
    Mosser, Annick
    Deugnier, Yves
    David, Veronique
    Brissot, Pierre
    Loreal, Olivier
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 720 - 724
  • [34] Advances in metal-induced oxidative stress and human disease
    Jomova, Klaudia
    Valko, Marian
    [J]. TOXICOLOGY, 2011, 283 (2-3) : 65 - 87
  • [35] Diagnosis and treatment of hereditary hemochromatosis: an update
    Kanwar, Pushpjeet
    Kowdley, Kris V.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (06) : 517 - 530
  • [36] Erythroferrone contributes to recovery from anemia of inflammation
    Kautz, Leon
    Jung, Grace
    Nemeth, Elizabeta
    Ganz, Tomas
    [J]. BLOOD, 2014, 124 (16) : 2569 - 2574
  • [37] Identification of erythroferrone as an erythroid regulator of iron metabolism
    Kautz, Leon
    Jung, Grace
    Valore, Erika V.
    Rivella, Stefano
    Nemeth, Elizabeta
    Ganz, Tomas
    [J]. NATURE GENETICS, 2014, 46 (07) : 678 - 684
  • [38] Aceruloplasminemia: An Update
    Kono, Satoshi
    [J]. METAL RELATED NEURODEGENERATIVE DISEASE, 2013, 110 : 125 - 151
  • [39] Second round robin for plasma hepcidin methods: First steps toward harmonization
    Kroot, Joyce J. C.
    van Herwaarden, Antonius E.
    Tjalsma, Harold
    Jansen, Rob T. P.
    Hendriks, Jan C. M.
    Swinkels, Dorine W.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 977 - 983
  • [40] Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment
    Larroche, Claire
    [J]. JOINT BONE SPINE, 2012, 79 (04) : 356 - 361